about
Seasonal changes in brain serotonin transporter binding in short serotonin transporter linked polymorphic region-allele carriers but not in long-allele homozygotesSerotonin 1B Receptor Binding Is Associated With Trait Anger and Level of Psychopathy in Violent OffendersEffects of vinpocetine on the redistribution of cerebral blood flow and glucose metabolism in chronic ischemic stroke patients: a PET studySerotonin 2A receptor agonist binding in the human brain with [¹¹C]Cimbi-36.Radiosynthesis and in vivo evaluation of a series of substituted 11C-phenethylamines as 5-HT (2A) agonist PET tracers.Design of Infusion Schemes for Neuroreceptor Imaging: Application to [(11)C]Flumazenil-PET Steady-State Study.Role of Serotonin Transporter Changes in Depressive Responses to Sex-Steroid Hormone Manipulation: A Positron Emission Tomography Study.Serotonin 2A receptor agonist binding in the human brain with [(11)C]Cimbi-36: Test-retest reproducibility and head-to-head comparison with the antagonist [(18)F]altanserin.Labeling and preliminary in vivo evaluation of the 5-HT(7) receptor selective agonist [(11)C]E-55888.[The role of PET scan among cardiologic imaging methods].[The [18F]-FNECA serves as a suitable radioligand for PET investigation of purinergic receptor expression].Development of a (11)C-labeled tetrazine for rapid tetrazine-trans-cyclooctene ligation.High brain serotonin levels in migraine between attacks: A 5-HT4 receptor binding PET study.The importance of small polar radiometabolites in molecular neuroimaging: A PET study with [11C]Cimbi-36 labeled in two positions.Convergent 18F-labeling and evaluation of N-benzyl-phenethylamines as 5-HT2A receptor PET ligands.Synthesis and evaluation of (18)F-labeled 5-HT2A receptor agonists as PET ligands.Loss of serotonin 2A receptors exceeds loss of serotonergic projections in early Alzheimer's disease: a combined [11C]DASB and [18F]altanserin-PET study.Evaluation of 3-Ethyl-3-(phenylpiperazinylbutyl)oxindoles as PET Ligands for the Serotonin 5-HT₇ Receptor: Synthesis, Pharmacology, Radiolabeling, and in Vivo Brain Imaging in Pigs.Radiolabelling and PET brain imaging of the α₁-adrenoceptor antagonist Lu AE43936.Radiosynthesis and Evaluation of [11C]3-Hydroxycyclopent-1-enecarboxylic Acid as Potential PET Ligand for the High-Affinity γ-Hydroxybutyric Acid Binding Sites.Development of a simple proton nuclear magnetic resonance-based procedure to estimate the approximate distribution coefficient at physiological pH (logD7.4): Evaluation and comparison to existing practices.Synthesis and evaluation of [¹¹C]Cimbi-806 as a potential PET ligand for 5-HT₇ receptor imaging.Brain serotonin 4 receptor binding is associated with the cortisol awakening response.11C-NS14492 as a novel PET radioligand for imaging cerebral alpha7 nicotinic acetylcholine receptors: in vivo evaluation and drug occupancy measurements.Cerebral serotonin 4 receptors and amyloid-β in early Alzheimer's disease.Synthesis, radiolabeling and in vivo evaluation of [(11)C](R)-1-[4-[2-(4-methoxyphenyl)phenyl]piperazin-1-yl]-3-(2-pyrazinyloxy)-2-propanol, a potential PET radioligand for the 5-HT(7) receptor.Design, synthesis, radiolabeling and in vivo evaluation of potential positron emission tomography (PET) radioligands for brain imaging of the 5-HT₇ receptor.Radiosynthesis and in vivo evaluation of novel radioligands for PET imaging of cerebral 5-HT7 receptors.[Synthesis of radiopharmaceuticals for PET investigations].Accelerating preclinical PET-screening: reductive amination with [11C]methoxybenzaldehydesHPLC methods for the purification of [11C]-labelled radiopharmaceuticals: reversal of the retention order of products and precursorsIn vivo evaluation of a series of substituted 11C-phenetylamines as 5-HT2A agonist PET tracers
P50
Q27115017-ce273c25-4932-58bb-65db-2860841ceb2fQ27230262-7476F4FF-1DB4-43B5-92AD-AC2D702F95CAQ28239178-1E5BACC8-02D0-4658-AEAB-0AA383910F50Q33851479-EFF0BA6B-821A-4919-8E1F-C43D6CB94455Q34025072-461E7A5F-1C8F-4632-B417-580F024D0B7BQ36795478-92F45EE9-1FA9-4F40-A42D-B62264E40876Q39003215-9727D727-B3FC-4007-89CA-B9FCCE2BB637Q39997514-6963DC6E-0B59-4143-9E2D-7AE6D629F3C1Q41096412-4806CECE-95BB-430D-BC0F-59F73B6F8038Q44037576-76A944CF-8AB0-4F03-B753-8A435DC42D2BQ44037581-0B7FA872-8EEC-45D7-A37B-22A2BDEE5876Q46912387-90DEC98E-67B3-4E2A-9BF2-3F7E3A037AD6Q47827409-74802669-CEA8-4EA1-A7FD-C61C417DF7A1Q47928428-A70AB3B9-1C21-46B4-B18C-036594FC02ECQ48041213-EC71192C-18A0-4FA3-A27F-37BD8D62A2EDQ48054775-B944AFE9-5B2E-4E4D-A109-D2BB8C536122Q48182063-C5D4D565-3FD3-4612-A979-F205C2EF71CEQ48253988-698CDFC1-E83C-4366-9AD8-82B5B953098AQ48287962-80F11EC4-B148-4294-8D35-7677CBF4A682Q48344927-0C7529AF-2AD9-4C43-B8FB-E78AB6BF2887Q48409938-5DE7C698-228F-41BC-92A3-C200879EF4B1Q48478689-AEFD2C2F-6E42-4406-9498-81D3715EC867Q48892729-C76FE6AB-C57A-4905-A477-CE65581A4C7FQ48956848-B9D71EF5-E595-464D-8D89-A58E448DFF27Q51004415-796A75B8-4D52-486D-AA5F-0B668EC18250Q51749237-66713A76-7C62-4487-A431-BB92D4546F53Q53010201-202BAA30-913C-4981-A364-73D3EE93400AQ53078055-86FA3034-610B-43BD-A7EC-49569CA6E40EQ53677467-4C10D6E6-3FD1-45BC-B676-FA9FEF94BA88Q57396183-D50D2006-252F-461F-B26E-71DC2FF7AFB6Q61634534-A98C25B6-D781-4083-967D-CE966CA1B246Q61634535-071DBAEE-F3DE-44D8-81C1-0257EF227808
P50
description
forsker
@da
onderzoeker
@nl
radiochemist
@en
name
Szabolcs Lehel
@ast
Szabolcs Lehel
@da
Szabolcs Lehel
@de
Szabolcs Lehel
@en
Szabolcs Lehel
@es
Szabolcs Lehel
@fo
Szabolcs Lehel
@fr
Szabolcs Lehel
@is
Szabolcs Lehel
@kl
Szabolcs Lehel
@nb
type
label
Szabolcs Lehel
@ast
Szabolcs Lehel
@da
Szabolcs Lehel
@de
Szabolcs Lehel
@en
Szabolcs Lehel
@es
Szabolcs Lehel
@fo
Szabolcs Lehel
@fr
Szabolcs Lehel
@is
Szabolcs Lehel
@kl
Szabolcs Lehel
@nb
prefLabel
Szabolcs Lehel
@ast
Szabolcs Lehel
@da
Szabolcs Lehel
@de
Szabolcs Lehel
@en
Szabolcs Lehel
@es
Szabolcs Lehel
@fo
Szabolcs Lehel
@fr
Szabolcs Lehel
@is
Szabolcs Lehel
@kl
Szabolcs Lehel
@nb
P106
P108
P2038
Szabolcs_Lehel
P21
P31
P6634
szabolcs-lehel-5307111a